Companies · Other Health Care

Seno Medical Instruments, Inc

SAN ANTONIO · Other Health Care

Diligence memoA one-page analyst read on Seno Medical Instruments, Inc — recommendation, valuation, rhythm, risks.
$63.2M
Total raised · real
6
Rounds
4.1×
Latest step-up
Top 7%
Sector rank · raised
Series B
Latest stage · inferred · Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)

Seno Medical Instruments, Inc looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.52× the median modeled value of Series B Other Health Care companies in 2013–2015 (85 peers) — value vs value, same stage and era.
Dormant
  • Last raise 12.5 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Seno Medical Instruments, Inc is one of 5377 Other Health Care companies tracked from SAN ANTONIO. By capital raised it ranks among the largest (ahead of 94% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeed · 2008-04-29 Raised $1.4M (real) Modeled valuation $35M (est)$1.4M$35MSeed2008Series A · 2010-10-19 Raised $5.0M (real) Modeled valuation $100M (est)$5.0M$100MSeries A2010Series A · 2010-10-19 Raised $4.6M (real) Modeled valuation $92M (est)$4.6M$92MSeries A2010Series A · 2012-03-09 Raised $15M (real) Modeled valuation $293M (est)$15M$293MSeries A2012Series A · 2012-03-09 Raised $7.4M (real) Modeled valuation $148M (est)$7.4M$148MSeries A2012Series B · 2013-12-31 Raised $30M (real) Modeled valuation $674M (est)$30M$674MSeries B2013+$5.0M+$4.6M+$15M+$7.4M+$30MCumulative $63M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.4M · 2008
Series A$5.0M · 2010
Series A extension$4.6M · 2010
Series A extension$14.5M · 2012
Series A extension$7.4M · 2012
Series B$30.4M · 2013

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$673.8M
Base estimate est.
$71.5M
Conservative case
$2.6B
Upside case
$169.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $34.7M · 2008-04-292008Series A · modeled $100.4M · 2010-10-19Series A · modeled $92.2M · 2010-10-19Series A · modeled $292.6M · 2012-03-09Series A · modeled $148.5M · 2012-03-09Series B · modeled $673.8M · 2013-12-312013
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
6.0 yr
Elapsed time used
12.5 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
14 mo
Avg between rounds
$11.1M/yr
Capital velocity
18.2 yr
On record since
2008
First round
6
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 26× above median
This company$63.2M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 1.7× above median
This company$30.4M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 30× above median
This company$673.8M
Sector median$22.1M

Raised more than 94% of sector peers (real $). Modeled value above 95% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #17 of 85.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)Drynachan, Llc · Series B Raised $40.0M · modeled $886.2M (est)Vistria SHC Holdings, LLC · Series B Raised $39.7M · modeled $879.5M (est)Ebh Holding Company, Inc. · Series B Raised $70.9M · modeled $871.1M (est)Orthopediatrics Corp · Series B Raised $57.5M · modeled $864.0M (est)Assurerx Health, Inc · Series B Raised $51.5M · modeled $828.4M (est)IMRIS Inc. · Series B Raised $36.8M · modeled $816.0M (est)Remedy Partners, Inc. · Series B Raised $56.4M · modeled $795.3M (est)Hansen Medical Inc · Series B Raised $126.0M · modeled $775.4M (est)BCOM Investment Partners, LLC · Series B Raised $34.5M · modeled $764.3M (est)Michigan Critical Care Consultants, Inc. · Series B Raised $34.0M · modeled $753.2M (est)HY Holdings, Inc. · Series B Raised $33.0M · modeled $731.1M (est)Medical Solutions L.L.C. · Series B Raised $32.5M · modeled $720.0M (est)Seno Medical Instruments, Inc (this company) Raised $63.2M · modeled $673.8M (est)Seno Medical Instruments, Inc
CompanyStageRaised · realValue · estvs peer med.
Drynachan, LlcSeries B$40.0M$886.2M2.00×
Vistria SHC Holdings, LLCSeries B$39.7M$879.5M1.99×
Ebh Holding Company, Inc.Series B$70.9M$871.1M1.97×
Orthopediatrics CorpSeries B$57.5M$864.0M1.95×
Assurerx Health, IncSeries B$51.5M$828.4M1.87×
IMRIS Inc.Series B$36.8M$816.0M1.84×
Remedy Partners, Inc.Series B$56.4M$795.3M1.79×
Hansen Medical IncSeries B$126.0M$775.4M1.75×
BCOM Investment Partners, LLCSeries B$34.5M$764.3M1.72×
Michigan Critical Care Consultants, Inc.Series B$34.0M$753.2M1.70×
HY Holdings, Inc.Series B$33.0M$731.1M1.65×
Medical Solutions L.L.C.Series B$32.5M$720.0M1.62×
Seno Medical Instruments, Inc this companySeries B$63.2M$673.8M1.52×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.4M2008-04-29$7.0M$34.7M90%
Series A$5.0M2010-10-19$22.6M$100.4M90%
Series A$4.6M2010-10-19$20.8M$92.2M90%
Series A$14.5M2012-03-09$65.9M$292.6M90%
Series A$7.4M2012-03-09$33.4M$148.5M90%
Series B$30.4M2013-12-31$169.0M$673.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.4M2008-04-29
    • First recorded raise — entered as Seed.
  2. Series A$5.0M2010-10-19
    • Raised again after 30 mo — slower than the ~14 mo sector norm.
    • Round 3.6× larger than the prior — scaling up.
  3. Series A$4.6M2010-10-19
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  4. Series A$14.5M2012-03-09
    • Raised 17 mo later, in step with the ~14 mo sector norm.
    • Round 3.2× larger than the prior — scaling up.
  5. Series A$7.4M2012-03-09
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.0× smaller than the prior — bridge or down round.
  6. Series B$30.4M2013-12-31
    • Raised again after 22 mo — slower than the ~14 mo sector norm.
    • Round 4.1× larger than the prior — scaling up.
Intelligence
2015 ~Q1
Modeled next raise · ~14mo cadence
$91.2M
Modeled next size est.range $59.3M$146.0M
4.1×
Last step-up
$11.1M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David Green7 other2008-04
Thomas W. Lyles, Jr.3 other2010-10
Janet Campbell2 other2008-04
Leo Womack2 other2008-04
GERARD SHERIDAN1 other2013-12
Joseph McNay1 other2008-04
Alexander Oraevsky2008-04
Gerard W. Sheridan2012-03
Harry Arturo Jacobson2013-12
Harry W. Jacobson2012-03
J. Arturo Bonilla2008-04
Martin Arturo Sandler2013-12
Martin P. Sandler2010-10
Ron Arturo Branstetter2010-10
Ron Branstetter2008-04
Thomas Arturo Lyles, Jr.2013-12
Thomas Arturo Miller2013-12
Thomas W. Miller2012-03
Registry & provenance

Seno Medical Instruments, Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1367976
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
MindCare Solutions Group, Inc.Other Health CareSeries B$30.5M$55.4Mnetwork1 shared operator · same sector · same stage
Teckro, Inc.Other Health CareSeries B$62.3M$366.4Msame sector · same stage
Arterys IncOther Health CareSeries B$61.6M$540.3Msame sector · same stage
Radisphere National Radiology Group, Inc.Other Health CareSeries B$65.1M$332.3Msame sector · same stage
HealthTell Inc.Other Health CareSeries B$60.5M$578.2Msame sector · same stage
Qt Ultrasound LlcOther Health CareSeries B$60.3M$572.1Msame sector · same stage
Cryolife IncOther Health CareSeries B$60.2M$420.5Msame sector · same stage
Venus Concept Ltd.Other Health CareSeries B$66.5M$311.3Msame sector · same stage
Frequently asked
How much funding has Seno Medical Instruments, Inc raised?
Seno Medical Instruments, Inc has raised approximately $63.2M in disclosed capital across 6 recorded financing rounds, aggregated from public filings.
What is Seno Medical Instruments, Inc's estimated valuation?
Provath's modeled valuation for Seno Medical Instruments, Inc is approximately $673.8M (modeled range $71.5M–$2.6B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Seno Medical Instruments, Inc at?
Seno Medical Instruments, Inc's latest modeled financing stage is Series B. Its most recent recorded round closed around Tue Dec 31.
What does Seno Medical Instruments, Inc do and where is it based?
Seno Medical Instruments, Inc operates in the Other Health Care sector, based in SAN ANTONIO.
Explore related

See where Seno Medical Instruments, Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Seno Medical Instruments, Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.